Apexium Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,557
Closed -$210K 239
2024
Q2
$210K Sell
3,557
-644
-15% -$40.3K 0.02% 213
2024
Q1
$335K Sell
4,201
-1,894
-31% -$145K 0.03% 169
2023
Q4
$481K Buy
6,095
+2,038
+50% +$145K 0.03% 174
2023
Q3
$283K Buy
4,057
+118
+3% +$8.36K 0.03% 177
2023
Q2
$272K Buy
3,939
+336
+9% +$23.9K 0.02% 183
2023
Q1
$268K Buy
3,603
+98
+3% +$8.22K 0.03% 180
2022
Q4
$327K Buy
3,505
+677
+24% +$65.3K 0.03% 159
2022
Q3
$270K Buy
+2,828
New +$280K 0.03% 163

Other funds holding CVS

Apexium Financial's CVS Position: Q3 2024 in Review

Apexium Financial sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,557 shares — an estimated $210K sold.

Apexium Financial first reported a position in CVS in Q3 2022 and held it in 8 quarters. The position peaked at $481K in Q4 2023. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Apexium Financial reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Apexium Financial sold 3,557 CVS Health shares in Q3 2024, an estimated $210K.
  • Apexium Financial first reported a position in CVS Health in Q3 2022 and held it in 8 quarters.
  • Apexium Financial's CVS Health position peaked at $481K in Q4 2023.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Apexium Financial's 13F filing for Q3 2024, filed 15 Oct 2024.